208 related articles for article (PubMed ID: 37108089)
21. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
[TBL] [Abstract][Full Text] [Related]
22. Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma.
Washimi K; Kasajima R; Shimizu E; Sato S; Okubo Y; Yoshioka E; Narimatsu H; Hiruma T; Katayama K; Yamaguchi R; Yamaguchi K; Furukawa Y; Miyano S; Imoto S; Yokose T; Miyagi Y
Sci Rep; 2023 Apr; 13(1):6744. PubMed ID: 37185612
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
24. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.
Gibault L; Pérot G; Chibon F; Bonnin S; Lagarde P; Terrier P; Coindre JM; Aurias A
J Pathol; 2011 Jan; 223(1):64-71. PubMed ID: 21125665
[TBL] [Abstract][Full Text] [Related]
25. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
26. Cytopathology of myxofibrosarcoma: a study of 66 cases and literature review.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):300-309. PubMed ID: 33041221
[TBL] [Abstract][Full Text] [Related]
27. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y
J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892
[TBL] [Abstract][Full Text] [Related]
28. Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
Iwata S; Yonemoto T; Araki A; Ikebe D; Kamoda H; Hagiwara Y; Ishii T
J Surg Oncol; 2014 Nov; 110(6):707-11. PubMed ID: 24975462
[TBL] [Abstract][Full Text] [Related]
29. Review of primary superficial soft tissue mesenchymal tumors of malignant or intermediate biological potential.
Oettel DJ; Bernard SA
Skeletal Radiol; 2023 Mar; 52(3):435-445. PubMed ID: 35867123
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions.
Das S; Idate R; Lana SE; Regan DP; Duval DL
Sci Rep; 2023 Jun; 13(1):10422. PubMed ID: 37369741
[TBL] [Abstract][Full Text] [Related]
31. Overview of malignant soft-tissue sarcomas of the limbs.
Renn A; Adejolu M; Messiou C; Bhaludin B; Strauss DC; Thway K; Moskovic E
Clin Radiol; 2021 Dec; 76(12):940.e1-940.e16. PubMed ID: 34607656
[TBL] [Abstract][Full Text] [Related]
32. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
Bahrami A; Folpe AL
Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
[TBL] [Abstract][Full Text] [Related]
33. The rare primary bone sarcomas: imaging-pathological correlation.
Berkeley R; Andrei V; Saifuddin A
Skeletal Radiol; 2021 Aug; 50(8):1491-1511. PubMed ID: 33410967
[TBL] [Abstract][Full Text] [Related]
34. Myxofibrosarcoma in adolescents and young adults: a clinicopathologic study of 17 cases.
Arispe Angulo KR; Logan S; Bahrami A; John I; Billings SD; Agrawal S; Bena J; Mesko N; Folpe AL; Fritchie KJ
Hum Pathol; 2023 Dec; 142():90-95. PubMed ID: 37742946
[TBL] [Abstract][Full Text] [Related]
35. Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma.
Bartlett EK; Sharma A; Seier K; Antonescu CR; Agaram NP; Jadeja B; Rosenbaum E; Chi P; Brennan MF; Qin LX; Alektiar KM; Singer S
JCO Precis Oncol; 2022 Oct; 6():e2200087. PubMed ID: 36240470
[TBL] [Abstract][Full Text] [Related]
36. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Moiseeva NI; Laletina LA; Fetisov TI; Makhmudova LF; Manikaylo AE; Fomina LY; Burov DA; Lesovaya EA; Bokhyan BY; Zinovieva VY; Vilkova AS; Mekheda LV; Kozlov NA; Scherbakov AM; Kirilin EM; Belitsky GA; Yakubovskaya MG; Kirsanov KI
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328603
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
[TBL] [Abstract][Full Text] [Related]
39. Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.
De Vita A; Recine F; Mercatali L; Miserocchi G; Spadazzi C; Liverani C; Bongiovanni A; Pieri F; Casadei R; Riva N; Fausti V; Amadori D; Ibrahim T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292724
[TBL] [Abstract][Full Text] [Related]
40. Myxofibrosarcoma primary cultures: molecular and pharmacological profile.
De Vita A; Recine F; Mercatali L; Miserocchi G; Liverani C; Spadazzi C; Casadei R; Bongiovanni A; Pieri F; Riva N; Amadori D; Ibrahim T
Ther Adv Med Oncol; 2017 Dec; 9(12):755-767. PubMed ID: 29449896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
